This site is intended for healthcare professionals

Go to /sign-in page

You can view 5 more pages before signing in

Go to /pro/cpd-dashboard page

This page is worth 0.05 CPD credits. CPD dashboard

Go to /account/subscription-details page

This page is worth 0.05 CPD credits. Upgrade to Pro

Treatment

Last reviewed dd mmm yyyy. Last edited dd mmm yyyy

Authoring team

It is most important to determine and then manage the underlying venous insufficiency.

Postural drainage may be used to counteract the high venous pressure. The patient should be encouraged to lie on the bed for an hour in the afternoon with the legs drained; similarly, they should be encouraged to sleep with the foot of the bed raised. Standing should be discouraged; exercise, encouraged.

Chronic use of topical steroids is not advised since they will accelerate the development of atrophy. Scratching and trauma may be prevented by the use of ichthyol or tar-impregnated bandages.

Mild eczema is treated with moderately potent corticosteroid for 3-4 weeks and emollients. Severe eczema may require higher potency corticosteroid treatment with emollients. Infected eczema may be treated with potent corticosteroids, antiseptic and astringent agent such as potassium permanganate (1:10000) and oral antibiotics (2).

Reference:


Create an account to add page annotations

Annotations allow you to add information to this page that would be handy to have on hand during a consultation. E.g. a website or number. This information will always show when you visit this page.

The content herein is provided for informational purposes and does not replace the need to apply professional clinical judgement when diagnosing or treating any medical condition. A licensed medical practitioner should be consulted for diagnosis and treatment of any and all medical conditions.

Connect

Copyright 2024 Oxbridge Solutions Limited, a subsidiary of OmniaMed Communications Limited. All rights reserved. Any distribution or duplication of the information contained herein is strictly prohibited. Oxbridge Solutions receives funding from advertising but maintains editorial independence.